Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology

Lorenzo Beretta, Francesca Bertolotti, Francesca Cappiello, Morena Barili, Michela Masciocchi, Karen Toussoun, Monica Caronni, Raffaella Scorza

Research output: Contribution to journalArticle

Abstract

Increased concentrations of interleukin-1 (IL-1) were observed in bronchoalveolar lavage fluids from patients with systemic sclerosis (SSc), and their levels were correlated with the patients' forced vital capacity (FVC). Because IL-1 production is regulated at the genetic level, we hypothesized that IL-1 gene complex single nucleotide polymorphisms (SNPs) might be relevant to the progression of ventilatory restriction in SSc. Two-hundred four Italian SSc patients were genotyped for the following IL-1 gene complex SNPs: IL-1α C-889T, IL-1β C+3962T, IL-1β C-511T, IL-1R Cpst1970T, and IL-1Ra Cmspal11100T, as well as for the following SNPs of cytokines with regulatory functions on IL-1 production: IFNγ AUTR5644T, TNFα A-308G, and IL-10 A-1082G. The SNPs were inserted in a Cox regression model with disease subset, gender, autoantibodies, age at onset of disease, and prior use of immunosoppresants as covariates and the presence of FVC <55% of predicted values as outcome measure; p values were corrected for the number of pairwise comparisons. Twenty-five patients (12.3%) developed a severe ventilatory restriction after 6.8 ± 6.6 years (mean ± standard deviation) from diagnosis. In our model, the relative risk to develop a severe ventilatory restriction was increased by the antitopoisomerase I antibody (p = 0.01; HR = 14.67, CI 95 = 1.87-114.92), the dcSSc subset (p = 0.007; HR = 3.14, CI 95 = 1.36-7.21) and the IL-1β C+3962T SNP (p = 0.003 TT vs CC; HR = 6.61, CI 95 = 2.28-19.15). The IL-1β C+3962T SNP is associated with the presence of severe restrictive lung physiology in Italian SSc patients.

Original languageEnglish
Pages (from-to)603-609
Number of pages7
JournalHuman Immunology
Volume68
Issue number7
DOIs
Publication statusPublished - Jul 2007

Fingerprint

Systemic Scleroderma
Interleukin-1
Lung
Single Nucleotide Polymorphism
Genes
Vital Capacity
Interleukin 1 Receptor Antagonist Protein
Bronchoalveolar Lavage Fluid
Age of Onset
Proportional Hazards Models
Interleukin-10
Autoantibodies
Outcome Assessment (Health Care)
Cytokines
Antibodies

Keywords

  • Interleukin-1
  • Interstitial lung disease
  • Single nucleotide polymorphism
  • Systemic sclerosis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. / Beretta, Lorenzo; Bertolotti, Francesca; Cappiello, Francesca; Barili, Morena; Masciocchi, Michela; Toussoun, Karen; Caronni, Monica; Scorza, Raffaella.

In: Human Immunology, Vol. 68, No. 7, 07.2007, p. 603-609.

Research output: Contribution to journalArticle

Beretta, Lorenzo ; Bertolotti, Francesca ; Cappiello, Francesca ; Barili, Morena ; Masciocchi, Michela ; Toussoun, Karen ; Caronni, Monica ; Scorza, Raffaella. / Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. In: Human Immunology. 2007 ; Vol. 68, No. 7. pp. 603-609.
@article{27613da2fdf44cb791e00040d086b239,
title = "Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology",
abstract = "Increased concentrations of interleukin-1 (IL-1) were observed in bronchoalveolar lavage fluids from patients with systemic sclerosis (SSc), and their levels were correlated with the patients' forced vital capacity (FVC). Because IL-1 production is regulated at the genetic level, we hypothesized that IL-1 gene complex single nucleotide polymorphisms (SNPs) might be relevant to the progression of ventilatory restriction in SSc. Two-hundred four Italian SSc patients were genotyped for the following IL-1 gene complex SNPs: IL-1α C-889T, IL-1β C+3962T, IL-1β C-511T, IL-1R Cpst1970T, and IL-1Ra Cmspal11100T, as well as for the following SNPs of cytokines with regulatory functions on IL-1 production: IFNγ AUTR5644T, TNFα A-308G, and IL-10 A-1082G. The SNPs were inserted in a Cox regression model with disease subset, gender, autoantibodies, age at onset of disease, and prior use of immunosoppresants as covariates and the presence of FVC <55{\%} of predicted values as outcome measure; p values were corrected for the number of pairwise comparisons. Twenty-five patients (12.3{\%}) developed a severe ventilatory restriction after 6.8 ± 6.6 years (mean ± standard deviation) from diagnosis. In our model, the relative risk to develop a severe ventilatory restriction was increased by the antitopoisomerase I antibody (p = 0.01; HR = 14.67, CI 95 = 1.87-114.92), the dcSSc subset (p = 0.007; HR = 3.14, CI 95 = 1.36-7.21) and the IL-1β C+3962T SNP (p = 0.003 TT vs CC; HR = 6.61, CI 95 = 2.28-19.15). The IL-1β C+3962T SNP is associated with the presence of severe restrictive lung physiology in Italian SSc patients.",
keywords = "Interleukin-1, Interstitial lung disease, Single nucleotide polymorphism, Systemic sclerosis",
author = "Lorenzo Beretta and Francesca Bertolotti and Francesca Cappiello and Morena Barili and Michela Masciocchi and Karen Toussoun and Monica Caronni and Raffaella Scorza",
year = "2007",
month = "7",
doi = "10.1016/j.humimm.2007.03.005",
language = "English",
volume = "68",
pages = "603--609",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology

AU - Beretta, Lorenzo

AU - Bertolotti, Francesca

AU - Cappiello, Francesca

AU - Barili, Morena

AU - Masciocchi, Michela

AU - Toussoun, Karen

AU - Caronni, Monica

AU - Scorza, Raffaella

PY - 2007/7

Y1 - 2007/7

N2 - Increased concentrations of interleukin-1 (IL-1) were observed in bronchoalveolar lavage fluids from patients with systemic sclerosis (SSc), and their levels were correlated with the patients' forced vital capacity (FVC). Because IL-1 production is regulated at the genetic level, we hypothesized that IL-1 gene complex single nucleotide polymorphisms (SNPs) might be relevant to the progression of ventilatory restriction in SSc. Two-hundred four Italian SSc patients were genotyped for the following IL-1 gene complex SNPs: IL-1α C-889T, IL-1β C+3962T, IL-1β C-511T, IL-1R Cpst1970T, and IL-1Ra Cmspal11100T, as well as for the following SNPs of cytokines with regulatory functions on IL-1 production: IFNγ AUTR5644T, TNFα A-308G, and IL-10 A-1082G. The SNPs were inserted in a Cox regression model with disease subset, gender, autoantibodies, age at onset of disease, and prior use of immunosoppresants as covariates and the presence of FVC <55% of predicted values as outcome measure; p values were corrected for the number of pairwise comparisons. Twenty-five patients (12.3%) developed a severe ventilatory restriction after 6.8 ± 6.6 years (mean ± standard deviation) from diagnosis. In our model, the relative risk to develop a severe ventilatory restriction was increased by the antitopoisomerase I antibody (p = 0.01; HR = 14.67, CI 95 = 1.87-114.92), the dcSSc subset (p = 0.007; HR = 3.14, CI 95 = 1.36-7.21) and the IL-1β C+3962T SNP (p = 0.003 TT vs CC; HR = 6.61, CI 95 = 2.28-19.15). The IL-1β C+3962T SNP is associated with the presence of severe restrictive lung physiology in Italian SSc patients.

AB - Increased concentrations of interleukin-1 (IL-1) were observed in bronchoalveolar lavage fluids from patients with systemic sclerosis (SSc), and their levels were correlated with the patients' forced vital capacity (FVC). Because IL-1 production is regulated at the genetic level, we hypothesized that IL-1 gene complex single nucleotide polymorphisms (SNPs) might be relevant to the progression of ventilatory restriction in SSc. Two-hundred four Italian SSc patients were genotyped for the following IL-1 gene complex SNPs: IL-1α C-889T, IL-1β C+3962T, IL-1β C-511T, IL-1R Cpst1970T, and IL-1Ra Cmspal11100T, as well as for the following SNPs of cytokines with regulatory functions on IL-1 production: IFNγ AUTR5644T, TNFα A-308G, and IL-10 A-1082G. The SNPs were inserted in a Cox regression model with disease subset, gender, autoantibodies, age at onset of disease, and prior use of immunosoppresants as covariates and the presence of FVC <55% of predicted values as outcome measure; p values were corrected for the number of pairwise comparisons. Twenty-five patients (12.3%) developed a severe ventilatory restriction after 6.8 ± 6.6 years (mean ± standard deviation) from diagnosis. In our model, the relative risk to develop a severe ventilatory restriction was increased by the antitopoisomerase I antibody (p = 0.01; HR = 14.67, CI 95 = 1.87-114.92), the dcSSc subset (p = 0.007; HR = 3.14, CI 95 = 1.36-7.21) and the IL-1β C+3962T SNP (p = 0.003 TT vs CC; HR = 6.61, CI 95 = 2.28-19.15). The IL-1β C+3962T SNP is associated with the presence of severe restrictive lung physiology in Italian SSc patients.

KW - Interleukin-1

KW - Interstitial lung disease

KW - Single nucleotide polymorphism

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=34250307119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250307119&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2007.03.005

DO - 10.1016/j.humimm.2007.03.005

M3 - Article

C2 - 17584583

AN - SCOPUS:34250307119

VL - 68

SP - 603

EP - 609

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 7

ER -